ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the role ...

Novo Nordisk’s Awiqli (insulin icodec) has been approved by the US FDA as the first and only once-weekly, long-acting basal ...

Sandoz has partnered with Samsung Bioepis to broaden patient access to high-quality biosimilar medicines worldwide. The ...

Stop losing momentum to the "logistics lag." The most successful life science teams have moved beyond fragmented spreadsheets ...

Roche has opened a new research facility for the Institute of Human Biology (IHB) in Basel, Switzerland. The building will ...

Novartis is to acquire Excellergy, a private biotech company developing next-generation anti-IgE therapies for IgE-driven ...

With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior ...

The Public Relations Global Network (PRGN) has announced that OVID Health, an independent public relations and public affairs ...

The digital age and the advance of AI have created a temptation to push communications to the furthest realms of personalisation, but that quest could also lure campaigns to the dark side of the moon ...

Current Chair, Dom Marchant, will be stepping down, but will continue to oversee the Creativity for Good initiative ...

Opdivo (nivolumab) has been approved for two new classical Hodgkin lymphoma (cHL) indications in the US and the EU. The US ...

Merck (known as MSD outside the US and Canada) has agreed on a multi-year research collaboration with Quotient Therapeutics in a deal that could be worth up to $2.2bn. Through the collaboration, the ...